DS3790 Enters Clinical Development as First DXd ADC in Hematology from Industry-Leading ADC Portfolio of Daiichi Sankyo
Astra wins FDA priority review for Daiichi's Datroway; denied approval for lupus therapy [Seeking Alpha]
DATROWAY® Granted Priority Review in the U.S. as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who Are Not Candidates for Immunotherapy
Banking on the long-term potential of oncology drugs: Daiichi Sankyo CFO [CNBC]
Promising New Weight-Loss Pill From South Korea’s Sam Chun Dang Pharm Mints Country’s Newest Billionaire [Forbes]